These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 28044259)

  • 21. Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the pro-apoptotic NF-κB.
    Buontempo F; Orsini E; Lonetti A; Cappellini A; Chiarini F; Evangelisti C; Evangelisti C; Melchionda F; Pession A; Bertaina A; Locatelli F; Bertacchini J; Neri LM; McCubrey JA; Martelli AM
    Oncotarget; 2016 Jan; 7(2):1323-40. PubMed ID: 26593250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy-induced alteration of SDF-1/CXCR4 expression in bone marrow-derived mesenchymal stem cells from adolescents and young adults with acute lymphoblastic leukemia.
    Ge J; Hu Y; Gui Y; Hou R; Yang M; Zeng Q; Xia R
    J Pediatr Hematol Oncol; 2014 Nov; 36(8):617-23. PubMed ID: 25072364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence of normal and neoplastic human B cell precursors to the bone marrow microenvironment.
    Ryan DH
    Blood Cells; 1993; 19(2):225-41; discussion 241-4. PubMed ID: 7906154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypical and functional characterization of bone marrow mesenchymal stem cells in patients with chronic graft-versus-host disease.
    Wang B; Hu Y; Liu L; Hu K; Tie R; He Y; Fu S; Zhu N; Luo Y; Yu X; Huang H
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1020-8. PubMed ID: 25708216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal stromal cells derived from the bone marrow of acute lymphoblastic leukemia patients show altered BMP4 production: correlations with the course of disease.
    Vicente López Á; Vázquez García MN; Melen GJ; Entrena Martínez A; Cubillo Moreno I; García-Castro J; Orellana MR; González AG
    PLoS One; 2014; 9(1):e84496. PubMed ID: 24400095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bortezomib enhances the osteogenic differentiation capacity of human mesenchymal stromal cells derived from bone marrow and placental tissues.
    Sanvoranart T; Supokawej A; Kheolamai P; U-Pratya Y; Klincumhom N; Manochantr S; Wattanapanitch M; Issaragrisil S
    Biochem Biophys Res Commun; 2014 May; 447(4):580-5. PubMed ID: 24747566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome.
    Oliveira E; Costa ES; Ciudad J; Gaipa G; Sedek Ł; Barrena S; Szczepanski T; Buracchi C; Silvestri D; Siqueira PFR; Mello FV; Torres RC; Oliveira LMR; Fay-Neves IVC; Sonneveld E; van der Velden VHJ; Mejstrikova E; Ribera JM; Conter V; Schrappe M; van Dongen JJM; Land MGP; Orfao A;
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disturbed CXCR4/CXCL12 axis in paediatric precursor B-cell acute lymphoblastic leukaemia.
    van den Berk LC; van der Veer A; Willemse ME; Theeuwes MJ; Luijendijk MW; Tong WH; van der Sluis IM; Pieters R; den Boer ML
    Br J Haematol; 2014 Jul; 166(2):240-9. PubMed ID: 24697337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone marrow-derived mesenchymal stem cells enhance autophagy via PI3K/AKT signalling to reduce the severity of ischaemia/reperfusion-induced lung injury.
    Li J; Zhou J; Zhang D; Song Y; She J; Bai C
    J Cell Mol Med; 2015 Oct; 19(10):2341-51. PubMed ID: 26177266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.
    Azab AK; Runnels JM; Pitsillides C; Moreau AS; Azab F; Leleu X; Jia X; Wright R; Ospina B; Carlson AL; Alt C; Burwick N; Roccaro AM; Ngo HT; Farag M; Melhem MR; Sacco A; Munshi NC; Hideshima T; Rollins BJ; Anderson KC; Kung AL; Lin CP; Ghobrial IM
    Blood; 2009 Apr; 113(18):4341-51. PubMed ID: 19139079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting.
    Chiarini F; Lonetti A; Evangelisti C; Buontempo F; Orsini E; Evangelisti C; Cappellini A; Neri LM; McCubrey JA; Martelli AM
    Biochim Biophys Acta; 2016 Mar; 1863(3):449-463. PubMed ID: 26334291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of bone marrow stromal cells on the chemotherapeutic sensitivity of acute lymphoblastic leukemia cells].
    Wang Y; Han ZX; Zhang JC
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):885-890. PubMed ID: 29262503
    [No Abstract]   [Full Text] [Related]  

  • 33. N-acetyl-L-cysteine improves mesenchymal stem cell function in prolonged isolated thrombocytopenia post-allotransplant.
    Kong Y; Song Y; Tang FF; Zhao HY; Chen YH; Han W; Yan CH; Wang Y; Zhang XH; Xu LP; Huang XJ
    Br J Haematol; 2018 Mar; 180(6):863-878. PubMed ID: 29392716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell adhesion-mediated mitochondria transfer contributes to mesenchymal stem cell-induced chemoresistance on T cell acute lymphoblastic leukemia cells.
    Wang J; Liu X; Qiu Y; Shi Y; Cai J; Wang B; Wei X; Ke Q; Sui X; Wang Y; Huang Y; Li H; Wang T; Lin R; Liu Q; Xiang AP
    J Hematol Oncol; 2018 Jan; 11(1):11. PubMed ID: 29357914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-cancer effects of Staphylococcal Enterotoxin type B on U266 cells co-cultured with Mesenchymal Stem Cells.
    Ejtehadifar M; Halabian R; Fooladi AAI; Ghazavi A; Mosayebi G
    Microb Pathog; 2017 Dec; 113():438-444. PubMed ID: 29170042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BCL6 modulation of acute lymphoblastic leukemia response to chemotherapy.
    Slone WL; Moses BS; Hare I; Evans R; Piktel D; Gibson LF
    Oncotarget; 2016 Apr; 7(17):23439-53. PubMed ID: 27015556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mouse bone marrow-derived mesenchymal stem cells inhibit leukemia/lymphoma cell proliferation in vitro and in a mouse model of allogeneic bone marrow transplant.
    Song N; Gao L; Qiu H; Huang C; Cheng H; Zhou H; Lv S; Chen L; Wang J
    Int J Mol Med; 2015 Jul; 36(1):139-49. PubMed ID: 25901937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetically engineered mesenchymal stromal cells produce IL-3 and TPO to further improve human scaffold-based xenograft models.
    Carretta M; de Boer B; Jaques J; Antonelli A; Horton SJ; Yuan H; de Bruijn JD; Groen RWJ; Vellenga E; Schuringa JJ
    Exp Hematol; 2017 Jul; 51():36-46. PubMed ID: 28456746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal stem cells derived from low risk acute lymphoblastic leukemia patients promote NK cell antitumor activity.
    Entrena A; Varas A; Vázquez M; Melen GJ; Fernández-Sevilla LM; García-Castro J; Ramírez M; Zapata AG; Vicente Á
    Cancer Lett; 2015 Jul; 363(2):156-65. PubMed ID: 25917077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesenchymal Stem Cells With Cancer-Associated Fibroblast-Like Phenotype Stimulate SDF-1/CXCR4 Axis to Enhance the Growth and Invasion of B-Cell Acute Lymphoblastic Leukemia Cells Through Cell-to-Cell Communication.
    Pan C; Fang Q; Liu P; Ma D; Cao S; Zhang L; Chen Q; Hu T; Wang J
    Front Cell Dev Biol; 2021; 9():708513. PubMed ID: 34733839
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.